Sana biotechnology to present pre-clinical data at 2021 american society of hematology annual meeting

Seattle, nov. 04, 2021 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that data will be presented during four poster presentations at the 63rd american society of hematology (ash) annual meeting and exposition, to be held both in person in atlanta, ga and virtually from sunday, december 11 to tuesday, december 14, 2021.
SANA Ratings Summary
SANA Quant Ranking